Gilead Sciences, Inc. 13D and 13G filings for AlloVir, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:54 pm Purchase | 2023-12-31 | 13G | AlloVir, Inc. ALVR | GILEAD SCIENCES INC. GILD | 723,273 14.600% | 127,429 (+21.39%) | Filing |
| 2022-08-05 5:52 pm Purchase | 2022-07-28 | 13G | AlloVir, Inc. ALVR | GILEAD SCIENCES INC. GILD | 595,844 14.800% | 595,844 (New Position) | Filing |